Your browser doesn't support javascript.
loading
Treatment of premenopausal patients with advanced or recurrent breast cancer by chemical ablation / 中国医学科学院学报
Acta Academiae Medicinae Sinicae ; (6): 60-62, 2003.
Artigo em Chinês | WPRIM | ID: wpr-301898
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the clinical efficacy and safety of luteinizing hormone releasing hormone (LH-RH) analog in premenopausal patients with advanced or recurrent breast cancer.</p><p><b>METHODS</b>LH-RH analog (enantone 3.75 mg/2 ml) were administered to 28 premenopausal patients with advanced recurrent breast cancer and its efficacy and side effect were observed.</p><p><b>RESULTS</b>The response rate (complete response and partial response) was 42.9%, and after 8 weeks of treatment, the plasma estrogen in all patients decreased to the level of postmenopause. No major adverse events were observed.</p><p><b>CONCLUSIONS</b>LH-RH analog is effective and safe for premenopausal breast cancer with low adverse reaction and its administration method is easy.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Sangue / Neoplasias da Mama / Hormônio Luteinizante / Hormônio Liberador de Gonadotropina / Leuprolida / Pré-Menopausa / Usos Terapêuticos / Tratamento Farmacológico / Estrogênios / Recidiva Local de Neoplasia Limite: Adulto / Feminino / Humanos Idioma: Chinês Revista: Acta Academiae Medicinae Sinicae Ano de publicação: 2003 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Sangue / Neoplasias da Mama / Hormônio Luteinizante / Hormônio Liberador de Gonadotropina / Leuprolida / Pré-Menopausa / Usos Terapêuticos / Tratamento Farmacológico / Estrogênios / Recidiva Local de Neoplasia Limite: Adulto / Feminino / Humanos Idioma: Chinês Revista: Acta Academiae Medicinae Sinicae Ano de publicação: 2003 Tipo de documento: Artigo